Trending Now
Akebia Therapeutics Inc. (NASDAQ:AKBA) Presents Positive INNO¬2VATE Phase 3 Clinical Vadadustat...
Akebia Therapeutics Inc. (NASDAQ:AKBA) has announced the presentation go its INNO2VATE Phase 3 clinical study data at the 2020 Reimagined American Society of Nephrology...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
IN8bio (Nasdaq: INAB) shares drop post results and here’s why
Biotech stocks can sometimes drop following the announcement of good news due to "profit-taking," where investors sell shares to realize gains, particularly...
MAKE IT MODERN
LATEST REVIEWS
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) Announce Positive PNV2 Data in Triple-Negative...
Adial Pharmaceuticals Inc. (NASDAQ: ADIL) has announced promising pre-clinical results for PNV2 in animal models for triple-negative breast cancer. Based on these results, the...
MAKE IT MODERN
PERFORMANCE TRAINING
Quantum-Si Incorporated (QSI): Transforming Proteomics with Next-Gen Protein Sequencing
Quantum-Si Incorporated (Nasdaq: QSI), “The Protein Sequencing Company™,” captured headlines with an extraordinary 67.44% surge in its stock price, closing at $3.60....
Akero Therapeutics Inc. (NASDAQ: AKRO) Completes Enrolment in Phase 2b HARMONY Study Of Efrixifermin...
Akero Therapeutics Inc. (NASDAQ: AKRO) has announced the completion of enrolment in the Phase 2b HARMONY trial of its novel FGF21, Efruxifermin (EFX) for...
Vaxart Inc. (NASDAQ: VXRT) Announces Progress in the Development of Its Oral COVID-19 Vaccine
Vaxart Inc. (NASDAQ: VXRT) has released its business update for Q3 2021, showing strong momentum in developing its oral vaccine platform that comprises tablet...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Enters Co-Promotion Partnership Deal For Probuphine Implant With Indegene
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it has signed a co-promotion partnership agreement with Indegene Inc. The partnership is meant to establish multichannel...
Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) Announces CRV431 Study Results In Liver Disease
Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) has announced results from its translational research study of CRV431, it's lead drug candidate. CRV431 demonstrated a decrease...
MAKE IT MODERN
